Status:
COMPLETED
ANTIBIOTIC-RESISTANT ENTEROBACTERALES BLOODSTREAM INFECTIONS AND RISK FACTORS IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Bloodstream Infections
Enterobacteriaceae Infections
Eligibility:
All Genders
18+ years
Brief Summary
In this study, we first aimed to reveal the resistance profile of Enterobacteriales bloodstream infections at our center. We evaluated data from patients with ESBL, colistin, and carbapenem resistanc...
Detailed Description
Antibiotic resistance represents one of the most urgent and serious challenges confronting modern healthcare systems. This problem is particularly critical in intensive care units (ICUs), where bloods...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Isolation of an Enterobacterales species from a blood culture obtained during ICU stay
- The isolate considered as the causative pathogen by an Infectious Diseases and Clinical Microbiology specialist
Exclusion
- Isolates not considered as causative pathogens
- Growth of a different pathogen in blood culture within ±72 hours of the index culture
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2023
Estimated Enrollment :
314 Patients enrolled
Trial Details
Trial ID
NCT07172932
Start Date
September 1 2019
End Date
January 30 2023
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Bilkent City Hospital
Çankaya, Ankara, Turkey (Türkiye), 06800